Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:24 Apr 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1417.40 [ +1.06% ]TCS 2328.10 [ +0.75% ]

Sensex29655.84
290.54 0.99%

Nifty9217.95
98.55 1.08%

Midcap14625.73
137.81 0.95%

Smallcap15291.26
124.95 0.82%


Bse Corporate Announcements Back
Taro gets final approval for the Imiquimod cream Sun Pharmaceuticals Industries has 48.7% stake, and
Taro gets final approval for the Imiquimod cream Sun Pharmaceuticals Industries has 48.7% stake, and 65.8% Voting rights in Taro Pharmaceuticals. Taro Pharmaceuticals has received final approval for Abbreviated New Drug Application (ANDA) from the US Food and Drug Administration (FDA) for Imiquimod cream 5%. It was originally developed and marketed by Graceway Pharmaceuticals under the brand name cream Aldara 5%. It is indicated for the treatment of actinic Keratosis and external genital warts. It has approximate annual sales of USD 340 million in the US market. Sun Pharmaceuticals Industries has 48.7% stake, and 65.8% Voting rights in Taro Pharmaceuticals.

Market on Mobile
























Site Map  •  Mobile  •  Companies  •  Learning Centre  •  Insurance •  About  •  Contact us  •  Disclaimer
© appuonline.com